<DOC>
	<DOCNO>NCT00863460</DOCNO>
	<brief_summary>Purpose study : To evaluate antitumoral effect two therapeutic procedure evaluate respective toxicity CNS .</brief_summary>
	<brief_title>Cranial Radiotherapy Intensive Chemotherapy With Hematopoietic Stem Cell Rescue Primary Central Nervous System Lymphoma Young Patients</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Cytarabine</mesh_term>
	<criteria>Histopathologically cytologically proven diagnostic Primary CNS lymphoma All histological type nonHodgkin 's lymphoma , except MALT Age &gt; 18 &lt; 60 an . Negative HIV , HCV HBV Written inform consent Age &lt; 18 &gt; 60 an Isolated intraocular lymphoma Previous history indolent lymphoma Previous chemotherapy radiotherapy PCNSL Isolated CNS relapse systemic NHL Previous history cancer last 5 year , except basocellular carcinoma non invasive cervix cancer Renal insufficiency creatinin clearance &lt; 60 ml/min Liver enzymes &gt; 3N . Platelets &lt; 100 000/mm3 neutrophil &lt; 1500/mm3 ) Previous history organ transplantation cause severe immunodeficiency Pregnancy active sexual woman contraception Unable follow protocol reason</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>